Volume 101, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



At baseline in 2006, Amhara National Regional State, Ethiopia, was the most trachoma-endemic region in the country. Trachoma impact surveys (TIS) were conducted in all districts between 2010 and 2015, following 3–5 years of intervention with the WHO-recommended SAFE (surgery, antibiotics, facial cleanliness, and environmental improvement) strategy. A multistage cluster random sampling design was used to estimate the district-level prevalence of trachoma. In total, 1,887 clusters in 152 districts were surveyed, from which 208,265 individuals from 66,089 households were examined for clinical signs of trachoma. The regional prevalence of trachomatous inflammation-follicular (TF) and trachomatous inflammation-intense among children aged 1–9 years was 25.9% (95% CI: 24.9–26.9) and 5.5% (95% CI: 5.2–6.0), respectively. The prevalence of trachomatous scarring and trachomatous trichiasis among adults aged ≥ 15 years was 12.9% (95% CI: 12.2–13.6) and 3.9% (95% CI: 3.7–4.1), respectively. Among children aged 1–9 years, 76.5% (95% CI: 75.3–77.7) presented with a clean face; 66.2% (95% CI: 64.1–68.2) of households had access to water within 30 minutes round-trip, 48.1% (95% CI: 45.5–50.6) used an improved water source, and 46.2% (95% CI: 44.8–47.5) had evidence of a used latrine. Nine districts had a prevalence of TF below the elimination threshold of 5%. In hyperendemic areas, 3–5 years of implementation of SAFE is insufficient to achieve trachoma elimination as a public health problem; additional years of SAFE and several rounds of TIS will be required before trachoma is eliminated.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. WHO, 2016. Validation of the Elimination of Trachoma as a Public Health Problem. Geneva, Switzerland: World Health Organization. [Google Scholar]
  2. WHO, 1997. Future Approaches to Trachoma Control. Geneva, Switzerland: World Health Organization. [Google Scholar]
  3. WHO, 2010. Report of the Third Global Scientific Meeting on Trachoma Elimination. Geneva, Switzerland: World Health Organization. [Google Scholar]
  4. Berhane Y, Worku A, Bejiga A, , 2006. National Survey on Blindness, Low Vision and Trachoma in Ethiopia. Addis Ababa, Ethiopia: Federal Ministry of Health. [Google Scholar]
  5. Ngondi J, 2009. Evaluation of three years of the safe strategy (surgery, antibiotics, facial cleanliness and environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachoma. Trans R Soc Trop Med Hyg 103: 10011010. [Google Scholar]
  6. Nash SD, 2018. Ocular Chlamydia trachomatis infection under the surgery, antibiotics, facial cleanliness, and environmental improvement strategy in amhara, Ethiopia, 2011–2015. Clin Infect Dis 67: 18401846. [Google Scholar]
  7. Emerson PM, 2008. Integrating an NTD with one of “the big three”: combined malaria and trachoma survey in Amhara region of Ethiopia. PLoS Negl Trop Dis 2: e197. [Google Scholar]
  8. BFEOD, 2006. Population Estimates by Ethiopia Bureau of Finance and Economic Development for the Year 2006/2007. Addis Ababa, Ethiopia: Ethiopia Bureau of Finance and Economic Development. [Google Scholar]
  9. The Carter Center, 2016. Summary Proceedings: All Eyes on 2020. 17th Annual Trachoma Program Review, March 7–9, 2016, Atlanta, GA. [Google Scholar]
  10. The Carter Center, 2008. Summary Proceedings: Ensuring Implementation of the Full Safe Strategy. Ninth Annual Trachoma Program Review, February 11–13, 2008, Atlanta, GA. [Google Scholar]
  11. The Carter Center, 2015. Summary Proceedings: Looking Back, Moving Forward. 16th Annual Trachoma Program Review, March 2–4, 2015, Atlanta, GA. [Google Scholar]
  12. The Carter Center, 2014. Summary Proceedings: Focus on Impact. 15th Annual Trachoma Program Review, February 25–27, 2014, Atlanta, GA. [Google Scholar]
  13. The Carter Center, 2013. Summary Proceedings: Efficient Program Delivery-Doing More, Better, Faster. 14th Annual Trachoma Control Program Review, March 11–13, 2013, Atlanta, GA. [Google Scholar]
  14. The Carter Center, 2012. Summary Proceedings: Shaping Programs to Fit the Need-Tthe Relevance of Prevalence. 13th Annual Trachoma Control Program Review, February 27–29, 2012, Atlanta, GA. [Google Scholar]
  15. The Carter Center, 2011. Summary Proceedings: Achieving Elimination Targets. 12th Annual Trachoma Control Program Review, February 22–24, 2011, Atlanta, GA. [Google Scholar]
  16. The Carter Center, 2010. Summary Proceedings: Planning for Trachoma Elimination, District by District. 11th Annual Trachoma Control Program Review, March 29–31, 2010, Atlanta, GA. [Google Scholar]
  17. The Carter Center, 2009. Summary Proceedings: From Control to Elimination. 10th Annual Trachoma Control Program Review, February 11–13, 2009, Atlanta, GA. [Google Scholar]
  18. Turner AG, Magnani RJ, Shuaib M, , 1996. A not quite as quick but much cleaner alternative to the expanded programme on immunization (epi) cluster survey design. Int J Epidemiol 25: 198203. [Google Scholar]
  19. King JD, 2014. Prevalence of trachoma at sub-district level in Ethiopia: determining when to stop mass azithromycin distribution. PLoS Negl Trop Dis 8: e2732. [Google Scholar]
  20. Minassian D, , 1997. Epidemiology in practice: sample size calculation for eye surveys: a simple method. J Comm Eye Health 10: 4244. [Google Scholar]
  21. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR, , 1987. A simple system for the assessment of trachoma and its complications. Bull World Health Organ 65: 477483. [Google Scholar]
  22. King JD, 2013. A novel electronic data collection system for large-scale surveys of neglected tropical diseases. PLoS One 8: e74570. [Google Scholar]
  23. WHO, Department of Control of Neglected Tropical Diseases, 2015. Technical Consultation on Trachoma Surveillance. Geneva, Switzerland: World Health Organization. [Google Scholar]
  24. Solomon AW, 2015. The global trachoma mapping project: methodology of a 34-country population-based study. Ophthalmic Epidemiol 22: 214225. [Google Scholar]
  25. Bamani S, King JD, Dembele M, Coulibaly F, Sankara D, Kamissoko Y, Ting J, Rotondo LA, Emerson PM, , 2010. Where do we go from here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, Mali. PLoS Negl Trop Dis 4: e734. [Google Scholar]
  26. West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC, , 2011. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania. J Infect Dis 204: 268273. [Google Scholar]
  27. Keenan JD, 2018. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: a continuation study of randomly reassigned subclusters (TANA II). PLoS Med 15: e1002633. [Google Scholar]
  28. Gebre T, 2012. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Lancet 379: 143151. [Google Scholar]
  29. Lietman T, Porco T, Dawson C, Blower S, , 1999. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med 5: 572576. [Google Scholar]
  30. Ray KJ, 2007. A rationale for continuing mass antibiotic distributions for trachoma. BMC Infect Dis 7: 91. [Google Scholar]
  31. Lakew T, 2009. Reduction and return of infectious trachoma in severely affected communities in Ethiopia. PLoS Negl Trop Dis 3: e376. [Google Scholar]
  32. Lietman TM, Pinsent A, Liu F, Deiner M, Hollingsworth TD, Porco TC, , 2018. Models of trachoma transmission and their policy implications: from control to elimination. Clin Infect Dis 66: S275S280. [Google Scholar]
  33. Melese M, 2008. Comparison of annual and biannual mass antibiotic administration for elimination of infectious trachoma. JAMA 299: 778784. [Google Scholar]
  34. Ramadhani AM, Derrick T, Macleod D, Holland MJ, Burton MJ, , 2016. The relationship between active trachoma and ocular Chlamydia trachomatis infection before and after mass antibiotic treatment. PLoS Negl Trop Dis 10: e0005080. [Google Scholar]
  35. West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey DC, , 2005. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 366: 12961300. [Google Scholar]
  36. Keenan JD, 2010. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma. Am J Trop Med Hyg 82: 482487. [Google Scholar]
  37. WHO, 2004. Report of the Eighth Meeting of the Who Alliance for the Global Elimination of Blinding Trachoma. Geneva, Switzerland: World Health Organization. [Google Scholar]
  38. Solomon AW, Zondervan M, Kuper H, Buchan J, Mabey D, Foster A, , 2006. Trachoma Control: A Guide for Programme Managers. Geneva, Switzerland: World Health Organization. [Google Scholar]
  39. International Trachoma Initiative, 2019. Zithromax Management Guide. Decatur, GA: International Trachoma Initiative. [Google Scholar]
  40. Adera TH, 2016. Prevalence of and risk factors for trachoma in southern nations, nationalities, and peoples’ region, Ethiopia: results of 40 population-based prevalence surveys carried out with the global trachoma mapping project. Ophthalmic Epidemiol 23: 8493. [Google Scholar]
  41. Bero B, 2016. Prevalence of and risk factors for trachoma in Oromia regional state of Ethiopia: results of 79 population-based prevalence surveys conducted with the global trachoma mapping project. Ophthalmic Epidemiol 23: 392405. [Google Scholar]

Data & Media loading...

Supplemental table

  • Received : 13 Jun 2019
  • Accepted : 29 Jul 2019
  • Published online : 23 Sep 2019

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error